paroxetine has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, P; Han, Y; Lai, J; Tai, Y; Tao, J; Wang, M; Wang, Q; Wang, Z; Zhou, W | 1 |
1 other study(ies) available for paroxetine and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Sustaining Circulating Regulatory T Cell Subset Contributes to the Therapeutic Effect of Paroxetine on Mice With Diabetic Cardiomyopathy.
Topics: Animals; Carvedilol; Cell Differentiation; Cells, Cultured; Diabetic Cardiomyopathies; Diet, High-Fat; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 2; Immunity; Insulin; Male; Mice; Mice, Inbred C57BL; Paroxetine; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Signal Transduction; T-Lymphocytes, Regulatory; Th17 Cells; Treatment Outcome | 2020 |